BSPM

Biostar Pharmaceuticals, Inc.
BSPM

Delisted

BSPM was delisted on the 18th of September, 2018.

7 hedge funds and large institutions have $330K invested in Biostar Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.18%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$124K 42,477 +42,477 New
AIM
2
Acrospire Investment Management
Illinois
$94K 32,019 +9,020 +39%
Morgan Stanley
3
Morgan Stanley
New York
$92K 31,398 +26,747 +575%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$12K 4,197
UBS Group
5
UBS Group
Switzerland
$7K 2,424 -4,072 -63%
Barclays
6
Barclays
United Kingdom
$1K 470 -347 -42%
VKH
7
Virtu KCG Holdings
New York
-17,163 Closed
CS
8
Credit Suisse
Switzerland
-11,023 Closed
Deutsche Bank
9
Deutsche Bank
Germany
$0 1